Manufacturer Copay Cards Document Financial Hardship in PI Cases

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 4, 2026 | 8 min read

When a personal injury plaintiff uses a manufacturer copay assistance card or patient assistance program to access medications, that enrollment itself constitutes documented evidence of financial hardship caused by the injury — a fact PI attorneys can leverage in damages arguments and to rebut defense claims of adequate insurance coverage.

Manufacturer Copay Cards Document Financial Hardship in PI Cases

A plaintiff's enrollment in a manufacturer copay assistance program or patient assistance program is not merely a billing mechanism. It is documented evidence that the plaintiff's injury-related medication costs exceeded their financial capacity, that their insurance coverage was inadequate for the prescribed treatment, and that they were forced to seek third-party financial assistance to access clinically necessary medications. Every copay card application is a financial hardship declaration that belongs in the damages narrative.

• Manufacturer copay card enrollment requires financial eligibility documentation that establishes hardship
• The existence of copay assistance proves the plaintiff's insurance was insufficient for injury-related medications
• Patient assistance program applications contain detailed financial disclosures that document economic impact
• LienScripts tracks medication access pathways including copay assistance to build complete case documentation
• As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, copay card enrollment is an underutilized piece of evidence that directly documents the economic burden of injury-related treatment

How Copay Assistance Programs Work

Pharmaceutical manufacturers offer copay assistance cards for brand-name medications that have high out-of-pocket costs even with insurance. These programs typically cover the difference between the patient's insurance copay and a reduced amount — sometimes reducing a several-hundred-dollar monthly copay to as little as zero.

Critically, these programs exist because the medications are expensive enough that patients cannot afford them even with insurance. The program's existence is an acknowledgment by the manufacturer that the drug's cost creates an access barrier.

For uninsured patients, many manufacturers offer Patient Assistance Programs (PAPs) that provide medications at no cost, but these require detailed financial disclosures — income documentation, proof of insurance status, and sometimes tax returns. Every piece of documentation submitted to a PAP is a financial hardship record that the attorney can reference in the damages narrative.

The Evidentiary Value

Insurance inadequacy. When a plaintiff with health insurance still needs copay assistance, this proves that their insurance coverage was insufficient for the injury-related treatment regimen. The defense cannot argue that the plaintiff had adequate insurance when the plaintiff demonstrably needed manufacturer subsidies to afford the prescribed medications.

Financial hardship documentation. PAP applications require the plaintiff to disclose their financial situation. If the plaintiff qualified for assistance — meaning their income fell below the program's threshold — this independently documents financial hardship. The application itself is a contemporaneous financial record created during the litigation period.

Medication necessity. A plaintiff does not go through the administrative burden of applying for copay assistance for medications they do not need. The effort required to enroll — applications, provider verification, periodic renewal — is itself evidence that the medication was important enough to the plaintiff's daily functioning that they took affirmative steps to maintain access.

Treatment complexity. Copay assistance cards are predominantly used for brand-name and specialty medications that lack affordable generic alternatives. The need for copay assistance signals that the plaintiff's condition required medications at the higher end of the treatment spectrum — further evidence of injury severity.

When Copay Cards Intersect with Pharmacy Liens

In some cases, plaintiffs use copay assistance before being enrolled in a pharmacy lien program, or for medications not covered by the lien. The copay assistance history from the pre-lien period documents the financial barrier that the pharmacy lien ultimately resolved. This timeline strengthens the narrative: the plaintiff struggled to afford medications, sought manufacturer assistance, and ultimately required a pharmacy lien to ensure consistent access.

LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages. When a plaintiff's medication history includes a period of copay assistance followed by enrollment in the LienScripts pharmacy lien program, the MERIT documentation captures this transition as part of the complete medication access narrative.

Practical Application for Attorneys

During case intake and throughout the litigation, attorneys should ask clients:

1. Are you using any manufacturer copay cards for your medications?
2. Have you applied to any patient assistance programs?
3. Were any medications discontinued because you could not afford the copay even with the assistance card?

Each affirmative answer adds to the financial hardship documentation. Retain copies of copay card enrollment confirmations and PAP approval letters — these are contemporaneous financial records that support the damages narrative.

For more on how insurance barriers create documentation opportunities, see Insurance Denial Appeal Letters as Expert Evidence. For additional context on how pharmacy liens bypass these financial barriers entirely, see Lien Pharmacy Bypasses Insurance Barriers in PI Cases.

The Bigger Picture

Every financial workaround a plaintiff employs to access injury-related medications — copay cards, patient assistance programs, borrowing from family, pharmacy lien enrollment — tells the same story: the injury created economic consequences that extended beyond medical bills into daily medication access. Documenting each of these workarounds builds a cumulative financial hardship narrative that strengthens the overall damages case.

Contact LienScripts to discuss how comprehensive medication access documentation strengthens your demand packages.